Back
Ingevity Vs. Aligos Therapeutics Industry Stock Comparison
Sell
13
NGVT
Ingevity
Last Price:
$41.44
Seasonality Move:
-4.08%
Sell
29
ALGS
Aligos Therapeutics
Last Price:
$32.59
Seasonality Move:
-18.25%
Sell
29
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $30.05. The Score for ALGS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NGVT Stock Price Chart
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.05The current trend is moderately bearish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.
NGVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.47 | Sell |
Relative Strength Index (14 RSI): | 43.31 | Sell |
Chaikin Money Flow: | 10571 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.01 - 44.99) | Sell |
Bollinger Bands (100): | (35.6 - 45.28) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.14 | Buy |
Relative Strength Index (14 RSI): | 41.89 | Sell |
Chaikin Money Flow: | -263729 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.95 - 41.43) | Sell |
Bollinger Bands (100): | (7.22 - 30.48) | Buy |
NGVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.13 | Buy |
20-day SMA: | 40.8 | Sell |
50-day SMA: | 44.19 | Sell |
200-day SMA: | 43.16 | Sell |
8-day EMA: | 39.47 | Buy |
20-day EMA: | 40.87 | Sell |
50-day EMA: | 41.96 | Sell |
200-day EMA: | 43.01 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.28 | Sell |
20-day SMA: | 38.13 | Sell |
50-day SMA: | 27.37 | Buy |
200-day SMA: | 17.35 | Buy |
8-day EMA: | 36.3 | Sell |
20-day EMA: | 36.12 | Sell |
50-day EMA: | 29.44 | Buy |
200-day EMA: | 20.26 | Buy |
Ingevity Earnings Growth & NGVT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and an increase next year of $0.92 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Ingevity Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |